Related Capabilities

Bio

Ms. Raptis has represented clients before the Federal Trade Commission and Department of Justice in numerous M&As, including NXP Semiconductors N.V. in its proposed but terminated acquisition by Qualcomm Incorporated; Gilead Sciences, Inc. in its acquisitions of Kite Pharma, Inc. and Pharmasett; Intel Corporation in its acquisition of Mobileye N.V.; TiVo Inc. in its sale to Rovi Corporation; SanDisk in its acquisition by Western Digital; Actavis in its acquisitions of Forest Laboratories and Warner Chilcott; Juno Therapeutics, Inc. in its acquisition by Celgene Corporation; Cineworld Group PLC in its $5.9 billion acquisition of Regal Entertainment Group; Hewlett Packard in its acquisition of Samsung’s printing business; Valeant in its acquisitions of Salix, Medicis, Dermik, Ortho Dermatologics and Biovail; Rite Aid in its acquisition of Envision Pharmaceutical Services; NDS Group in its acquisition by Cisco Systems; Watson in its acquisitions of Actavis and Andrx; and StorageTek in its acquisition by Sun Microsystems.

Ms. Raptis’ litigation experience includes defending Actavis in suits brought by the FTC and private plaintiffs relating to "reverse payment" settlements for Androgel, representing Bausch & Lomb in connection with litigation challenging its pricing policies relating to disposable contact lenses, representing Actavis in a multidistrict litigation relating to patent settlements for Lidoderm and defending De Beers in connection with national class actions involving gem diamonds.

Ms. Raptis also has represented clients in connection with allegations of price-fixing or other criminal charges, including De Beers in connection with the resolution of a criminal matter relating to industrial diamonds.